Page last updated: 2024-10-26

etidronate and Back Pain

etidronate has been researched along with Back Pain in 18 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Back Pain: Acute or chronic pain located in the posterior regions of the THORAX; LUMBOSACRAL REGION; or the adjacent regions.

Research Excerpts

ExcerptRelevanceReference
"The purpose of the present study was to compare the effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living (ADL) in elderly women with vertebral fractures."9.10Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures. ( Ichimura, S; Iwamoto, J; Takeda, T; Uzawa, M, 2003)
"A case of osteogenesis imperfecta (OI) that was successfully treated with oral etidronate and alfacalcidol is reported."7.72Effects of treatment with etidronate and alfacalcidol for osteogenesis imperfecta type I: a case report. ( Ichimura, S; Iwamoto, J; Matsu, K; Takeda, T; Uzawa, M, 2003)
"The purpose of this open-labeled prospective study was to compare the treatment effects of cyclical etidronate and alendronate on the lumbar bone mineral density (BMD), bone resorption, and back pain in elderly women with osteoporosis."5.11Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis. ( Iwamoto, J; Sato, Y; Takeda, T; Uzawa, M, 2005)
"The purpose of the present study was to examine the early response of lumbar bone mineral density (BMD), bone resorption, and back pain to alendronate after treatment with cyclical etidronate in postmenopausal women with osteoporosis."5.10Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis. ( Ichimura, S; Iwamoto, J; Takeda, T; Uzawa, M, 2003)
"The purpose of the present study was to compare the effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living (ADL) in elderly women with vertebral fractures."5.10Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures. ( Ichimura, S; Iwamoto, J; Takeda, T; Uzawa, M, 2003)
"A case of osteogenesis imperfecta (OI) that was successfully treated with oral etidronate and alfacalcidol is reported."3.72Effects of treatment with etidronate and alfacalcidol for osteogenesis imperfecta type I: a case report. ( Ichimura, S; Iwamoto, J; Matsu, K; Takeda, T; Uzawa, M, 2003)
" These results suggested that ECT in combination with risedronate was more effective than risedronate alone for reducing back pain in postmenopausal women with osteoporosis."2.77Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis. ( Iwamoto, J; Takakuwa, M, 2012)
"Back and knee pain is a widespread health problem and a serious threat to the quality of life (QOL) in middle-aged and older adults, as it frequently accompanies osteoporosis and osteoarthritis."2.76Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36. ( Fujii, Y; Fujita, T; Miyauchi, A; Nakajima, M; Ohue, M; Takagi, Y, 2011)
"Osteoporosis is a common condition in men that can have serious clinical consequences."2.74Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. ( Dorst, A; Faber, H; Farahmand, P; Ringe, JD, 2009)
"Osteoporosis is prevalent in men with an estimated one in eight men older than 50 years suffering from osteoporotic fracture, and a higher mortality rate after fracture among men compared with women."2.72Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. ( Dorst, A; Faber, H; Farahmand, P; Ringe, JD, 2006)

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19902 (11.11)18.7374
1990's2 (11.11)18.2507
2000's9 (50.00)29.6817
2010's5 (27.78)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ringe, JD2
Farahmand, P2
Faber, H2
Dorst, A2
Majima, T1
Shimatsu, A1
Komatsu, Y1
Satoh, N1
Fukao, A1
Ninomiya, K1
Matsumura, T1
Nakao, K1
Orita, S1
Ohtori, S1
Koshi, T1
Yamashita, M1
Yamauchi, K1
Inoue, G1
Suzuki, M1
Eguchi, Y1
Kamoda, H1
Arai, G1
Ishikawa, T1
Miyagi, M1
Ochiai, N1
Kishida, S1
Takaso, M1
Aoki, Y1
Toyone, T1
Takahashi, K1
Vujasinovic-Stupar, N1
Pejnovic, N1
Markovic, L1
Zlatanovic, M1
Fujita, T2
Ohue, M1
Nakajima, M1
Fujii, Y2
Miyauchi, A2
Takagi, Y2
Hadji, P1
Zanchetta, JR1
Russo, L1
Recknor, CP1
Saag, KG1
McKiernan, FE1
Silverman, SL1
Alam, J1
Burge, RT1
Krege, JH1
Lakshmanan, MC1
Masica, DN1
Mitlak, BH1
Stock, JL1
Takakuwa, M1
Iwamoto, J5
Matsu, K1
Takeda, T4
Ichimura, S3
Uzawa, M4
Kishimoto, H1
Sato, Y1
Pfannenstiel, P1
Semmler, U1
Adam, W1
Halbsguth, A1
Bandilla, K1
Berg, D1
Hosie, G1
Albert, S1
Glynn, C1
Okada, SF1
Chong, WK1
Cunningham, DA1
Altman, RD1
Brown, M1
Gargano, F1

Reviews

2 reviews available for etidronate and Back Pain

ArticleYear
[Risedronate treatment for osteoporosis].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 2

    Topics: Back Pain; Bone Density; Bone Resorption; Clinical Trials as Topic; Etidronic Acid; Femoral Neck Fra

2004
Case report: intravenous etidronate as a cause of poor uptake on bone scanning, with a review of the literature.
    Clinical radiology, 1991, Volume: 44, Issue:4

    Topics: Aged; Back Pain; Bone and Bones; Etidronic Acid; Humans; Liver Neoplasms; Male; Radionuclide Imaging

1991

Trials

10 trials available for etidronate and Back Pain

ArticleYear
Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study.
    Rheumatology international, 2009, Volume: 29, Issue:3

    Topics: Aged; Back Pain; Bone Density Conservation Agents; Calcium; Drug Therapy, Combination; Etidronic Aci

2009
Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study.
    Journal of bone and mineral metabolism, 2009, Volume: 27, Issue:2

    Topics: Aged; Asian People; Back Pain; Body Height; Bone Density; Bone Density Conservation Agents; Bone Rem

2009
Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36.
    Journal of bone and mineral metabolism, 2011, Volume: 29, Issue:5

    Topics: Aged; Back Pain; Bone Density Conservation Agents; Calcitonin; Etidronic Acid; Female; Humans; Knee

2011
The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012, Volume: 23, Issue:8

    Topics: Aged; Back Pain; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Etidronic Acid

2012
Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:7

    Topics: Aged; Aged, 80 and over; Analgesics; Back Pain; Bone Density; Bone Density Conservation Agents; Calc

2012
Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis.
    The Keio journal of medicine, 2003, Volume: 52, Issue:2

    Topics: Aged; Aged, 80 and over; Alendronate; Back Pain; Bone Density; Calcium; Collagen; Collagen Type I; E

2003
Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures.
    The Keio journal of medicine, 2003, Volume: 52, Issue:4

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alendronate; Back Pain; Bone Resorption; Disabi

2003
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study.
    Rheumatology international, 2006, Volume: 26, Issue:5

    Topics: Aged; Back Pain; Bone Density; Bone Density Conservation Agents; Calcium; Etidronic Acid; Fractures,

2006
Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis.
    Yonsei medical journal, 2005, Dec-31, Volume: 46, Issue:6

    Topics: Aged; Aged, 80 and over; Alendronate; Back Pain; Biomarkers; Bone Density; Bone Density Conservation

2005
Analgesic effect of etidronate on degenerative joint disease.
    Journal of bone and mineral metabolism, 2001, Volume: 19, Issue:4

    Topics: Aged; Analgesics, Non-Narcotic; Back Pain; Bone Density; Dose-Response Relationship, Drug; Etidronic

2001

Other Studies

6 other studies available for etidronate and Back Pain

ArticleYear
The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation.
    Spine, 2010, Oct-15, Volume: 35, Issue:22

    Topics: Afferent Pathways; Animals; Back Pain; Bone Density Conservation Agents; Cells, Cultured; Disease Mo

2010
Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome.
    Rheumatology international, 2012, Volume: 32, Issue:3

    Topics: Adult; Back Pain; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Etidronic A

2012
Effects of treatment with etidronate and alfacalcidol for osteogenesis imperfecta type I: a case report.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2003, Volume: 8, Issue:2

    Topics: Adult; Back Pain; Bone Density; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxycholecalci

2003
Comparative study of quantitating 99mTc-EHDP uptake in sacroiliac scintigraphy.
    European journal of nuclear medicine, 1980, Volume: 5, Issue:1

    Topics: Back Pain; Etidronic Acid; Humans; Methods; Radionuclide Imaging; Sacroiliac Joint; Technetium

1980
Osteoporotic vertebral collapse in a woman.
    The Practitioner, 1994, Volume: 238, Issue:1539

    Topics: Aged; Back Pain; Estrogen Replacement Therapy; Etidronic Acid; Female; Humans; Osteoporosis; Spinal

1994
Low back pain in Paget's disease of bone.
    Clinical orthopaedics and related research, 1987, Issue:217

    Topics: Back Pain; Diagnosis, Differential; Etidronic Acid; Humans; Osteitis Deformans; Osteoarthritis; Radi

1987